Product
AdvVEGF-D
1 clinical trial
3 indications
Indication
Refractory Angina PectorisIndication
Gene TransferIndication
Coronary Artery DiseaseClinical trial
Clinical Development and Proof of Principle Testing of New Regenerative Adenovirus Vascular Endothelial Growth Factor (VEGF-D) Therapy for Cost-effective Treatment of Refractory Angina. A Phase II Randomized, Double-blinded, Placebo-controlled Study (ReGenHeart)Status: Active (not recruiting), Estimated PCD: 2023-12-31